cloudfront

Report Detail



OtherGlobal In Situ Hybridization (ISH) Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • RnM2414276
  • |
  • 14 September, 2018
  • |
  • Global
  • |
  • 117 pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Global In Situ Hybridization (ISH) Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Table of Contents

    1 In Situ Hybridization (ISH) Market Overview

    • 1.1 Product Overview and Scope of In Situ Hybridization (ISH)
    • 1.2 Classification of In Situ Hybridization (ISH) by Types
    • 1.2.1 Global In Situ Hybridization (ISH) Revenue Comparison by Types (2017-2023)
  • 1.2.2 Global In Situ Hybridization (ISH) Revenue Market Share by Types in 2017
  • 1.2.3 Instruments
  • 1.2.4 Kits & Probes
  • 1.2.5 Software
  • 1.2.6 Services
  • 1.3 Global In Situ Hybridization (ISH) Market by Application
  • 1.3.1 Global In Situ Hybridization (ISH) Market Size and Market Share Comparison by Applications (2013-2023)
  • 1.3.2 Cancer
  • 1.3.3 Cytogenetics
  • 1.3.4 Developmental Biology
  • 1.3.5 Infectious Diseases
  • 1.3.6 Others
  • 1.4 Global In Situ Hybridization (ISH) Market by Regions
  • 1.4.1 Global In Situ Hybridization (ISH) Market Size (Million USD) Comparison by Regions (2013-2023)
  • 1.4.1 North America (USA, Canada and Mexico) In Situ Hybridization (ISH) Status and Prospect (2013-2023)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) In Situ Hybridization (ISH) Status and Prospect (2013-2023)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) In Situ Hybridization (ISH) Status and Prospect (2013-2023)
  • 1.4.4 South America (Brazil, Argentina, Colombia) In Situ Hybridization (ISH) Status and Prospect (2013-2023)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) In Situ Hybridization (ISH) Status and Prospect (2013-2023)
  • 1.5 Global Market Size of In Situ Hybridization (ISH) (2013-2023)
  • 2 Manufacturers Profiles

    • 2.1 Thermo Fisher Scientific
    • 2.1.1 Business Overview
  • 2.1.2 In Situ Hybridization (ISH) Type and Applications
  • 2.1.2.1 Product A
  • 2.1.2.2 Product B
  • 2.1.3 Thermo Fisher Scientific In Situ Hybridization (ISH) Revenue, Gross Margin and Market Share (2016-2017)
  • 2.2 Leica BiosystemsNussloch GmbH
  • 2.2.1 Business Overview
  • 2.2.2 In Situ Hybridization (ISH) Type and Applications
  • 2.2.2.1 Product A
  • 2.2.2.2 Product B
  • 2.2.3 Leica BiosystemsNussloch GmbH In Situ Hybridization (ISH) Revenue, Gross Margin and Market Share (2016-2017)
  • 2.3 BIOVIEW
  • 2.3.1 Business Overview
  • 2.3.2 In Situ Hybridization (ISH) Type and Applications
  • 2.3.2.1 Product A
  • 2.3.2.2 Product B
  • 2.3.3 BIOVIEW In Situ Hybridization (ISH) Revenue, Gross Margin and Market Share (2016-2017)
  • 2.4 Agilent Technologies
  • 2.4.1 Business Overview
  • 2.4.2 In Situ Hybridization (ISH) Type and Applications
  • 2.4.2.1 Product A
  • 2.4.2.2 Product B
  • 2.4.3 Agilent Technologies In Situ Hybridization (ISH) Revenue, Gross Margin and Market Share (2016-2017)
  • 2.5 Merck KGaA
  • 2.5.1 Business Overview
  • 2.5.2 In Situ Hybridization (ISH) Type and Applications
  • 2.5.2.1 Product A
  • 2.5.2.2 Product B
  • 2.5.3 Merck KGaA In Situ Hybridization (ISH) Revenue, Gross Margin and Market Share (2016-2017)
  • 2.6 PerkinElmer Inc.
  • 2.6.1 Business Overview
  • 2.6.2 In Situ Hybridization (ISH) Type and Applications
  • 2.6.2.1 Product A
  • 2.6.2.2 Product B
  • 2.6.3 PerkinElmer Inc. In Situ Hybridization (ISH) Revenue, Gross Margin and Market Share (2016-2017)
  • 2.7 Bio-Rad Laboratories Inc.
  • 2.7.1 Business Overview
  • 2.7.2 In Situ Hybridization (ISH) Type and Applications
  • 2.7.2.1 Product A
  • 2.7.2.2 Product B
  • 2.7.3 Bio-Rad Laboratories Inc. In Situ Hybridization (ISH) Revenue, Gross Margin and Market Share (2016-2017)
  • 2.8 NeoGenomics Laboratories Inc.
  • 2.8.1 Business Overview
  • 2.8.2 In Situ Hybridization (ISH) Type and Applications
  • 2.8.2.1 Product A
  • 2.8.2.2 Product B
  • 2.8.3 NeoGenomics Laboratories Inc. In Situ Hybridization (ISH) Revenue, Gross Margin and Market Share (2016-2017)
  • 2.9 Advanced Cell Diagnostics Inc.
  • 2.9.1 Business Overview
  • 2.9.2 In Situ Hybridization (ISH) Type and Applications
  • 2.9.2.1 Product A
  • 2.9.2.2 Product B
  • 2.9.3 Advanced Cell Diagnostics Inc. In Situ Hybridization (ISH) Revenue, Gross Margin and Market Share (2016-2017)
  • 2.10 Oxford Gene Technology
  • 2.10.1 Business Overview
  • 2.10.2 In Situ Hybridization (ISH) Type and Applications
  • 2.10.2.1 Product A
  • 2.10.2.2 Product B
  • 2.10.3 Oxford Gene Technology In Situ Hybridization (ISH) Revenue, Gross Margin and Market Share (2016-2017)
  • 3 Global In Situ Hybridization (ISH) Market Competition, by Players

    • 3.1 Global In Situ Hybridization (ISH) Revenue and Share by Players (2013-2018)
    • 3.2 Market Concentration Rate
    • 3.2.1 Top 5 In Situ Hybridization (ISH) Players Market Share
  • 3.2.2 Top 10 In Situ Hybridization (ISH) Players Market Share
  • 3.3 Market Competition Trend
  • 4 Global In Situ Hybridization (ISH) Market Size by Regions

    • 4.1 Global In Situ Hybridization (ISH) Revenue and Market Share by Regions
    • 4.2 North America In Situ Hybridization (ISH) Revenue and Growth Rate (2013-2018)
    • 4.3 Europe In Situ Hybridization (ISH) Revenue and Growth Rate (2013-2018)
    • 4.4 Asia-Pacific In Situ Hybridization (ISH) Revenue and Growth Rate (2013-2018)
    • 4.5 South America In Situ Hybridization (ISH) Revenue and Growth Rate (2013-2018)
    • 4.6 Middle East and Africa In Situ Hybridization (ISH) Revenue and Growth Rate (2013-2018)

    5 North America In Situ Hybridization (ISH) Revenue by Countries

    • 5.1 North America In Situ Hybridization (ISH) Revenue by Countries (2013-2018)
    • 5.2 USA In Situ Hybridization (ISH) Revenue and Growth Rate (2013-2018)
    • 5.3 Canada In Situ Hybridization (ISH) Revenue and Growth Rate (2013-2018)
    • 5.4 Mexico In Situ Hybridization (ISH) Revenue and Growth Rate (2013-2018)

    6 Europe In Situ Hybridization (ISH) Revenue by Countries

    • 6.1 Europe In Situ Hybridization (ISH) Revenue by Countries (2013-2018)
    • 6.2 Germany In Situ Hybridization (ISH) Revenue and Growth Rate (2013-2018)
    • 6.3 UK In Situ Hybridization (ISH) Revenue and Growth Rate (2013-2018)
    • 6.4 France In Situ Hybridization (ISH) Revenue and Growth Rate (2013-2018)
    • 6.5 Russia In Situ Hybridization (ISH) Revenue and Growth Rate (2013-2018)
    • 6.6 Italy In Situ Hybridization (ISH) Revenue and Growth Rate (2013-2018)

    7 Asia-Pacific In Situ Hybridization (ISH) Revenue by Countries

    • 7.1 Asia-Pacific In Situ Hybridization (ISH) Revenue by Countries (2013-2018)
    • 7.2 China In Situ Hybridization (ISH) Revenue and Growth Rate (2013-2018)
    • 7.3 Japan In Situ Hybridization (ISH) Revenue and Growth Rate (2013-2018)
    • 7.4 Korea In Situ Hybridization (ISH) Revenue and Growth Rate (2013-2018)
    • 7.5 India In Situ Hybridization (ISH) Revenue and Growth Rate (2013-2018)
    • 7.6 Southeast Asia In Situ Hybridization (ISH) Revenue and Growth Rate (2013-2018)

    8 South America In Situ Hybridization (ISH) Revenue by Countries

    • 8.1 South America In Situ Hybridization (ISH) Revenue by Countries (2013-2018)
    • 8.2 Brazil In Situ Hybridization (ISH) Revenue and Growth Rate (2013-2018)
    • 8.3 Argentina In Situ Hybridization (ISH) Revenue and Growth Rate (2013-2018)
    • 8.4 Colombia In Situ Hybridization (ISH) Revenue and Growth Rate (2013-2018)

    9 Middle East and Africa Revenue In Situ Hybridization (ISH) by Countries

    • 9.1 Middle East and Africa In Situ Hybridization (ISH) Revenue by Countries (2013-2018)
    • 9.2 Saudi Arabia In Situ Hybridization (ISH) Revenue and Growth Rate (2013-2018)
    • 9.3 UAE In Situ Hybridization (ISH) Revenue and Growth Rate (2013-2018)
    • 9.4 Egypt In Situ Hybridization (ISH) Revenue and Growth Rate (2013-2018)
    • 9.5 Nigeria In Situ Hybridization (ISH) Revenue and Growth Rate (2013-2018)
    • 9.6 South Africa In Situ Hybridization (ISH) Revenue and Growth Rate (2013-2018)

    10 Global In Situ Hybridization (ISH) Market Segment by Type

    • 10.1 Global In Situ Hybridization (ISH) Revenue and Market Share by Type (2013-2018)
    • 10.2 Global In Situ Hybridization (ISH) Market Forecast by Type (2018-2023)
    • 10.3 Instruments Revenue Growth Rate (2013-2023)
    • 10.4 Kits & Probes Revenue Growth Rate (2013-2023)
    • 10.5 Software Revenue Growth Rate (2013-2023)
    • 10.6 Services Revenue Growth Rate (2013-2023)

    11 Global In Situ Hybridization (ISH) Market Segment by Application

    • 11.1 Global In Situ Hybridization (ISH) Revenue Market Share by Application (2013-2018)
    • 11.2 In Situ Hybridization (ISH) Market Forecast by Application (2018-2023)
    • 11.3 Cancer Revenue Growth (2013-2018)
    • 11.4 Cytogenetics Revenue Growth (2013-2018)
    • 11.5 Developmental Biology Revenue Growth (2013-2018)
    • 11.6 Infectious Diseases Revenue Growth (2013-2018)
    • 11.7 Others Revenue Growth (2013-2018)

    12 Global In Situ Hybridization (ISH) Market Size Forecast (2018-2023)

    • 12.1 Global In Situ Hybridization (ISH) Market Size Forecast (2018-2023)
    • 12.2 Global In Situ Hybridization (ISH) Market Forecast by Regions (2018-2023)
    • 12.3 North America In Situ Hybridization (ISH) Revenue Market Forecast (2018-2023)
    • 12.4 Europe In Situ Hybridization (ISH) Revenue Market Forecast (2018-2023)
    • 12.5 Asia-Pacific In Situ Hybridization (ISH) Revenue Market Forecast (2018-2023)
    • 12.6 South America In Situ Hybridization (ISH) Revenue Market Forecast (2018-2023)
    • 12.7 Middle East and Africa In Situ Hybridization (ISH) Revenue Market Forecast (2018-2023)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand (i.e., probe) to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough (e.g., plant seeds, Drosophila embryos), in the entire tissue (whole mount ISH), in cells, and in circulating tumor cells (CTCs).

      Scope of the Report:

      This report studies the In Situ Hybridization (ISH) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the In Situ Hybridization (ISH) market by product type and applications/end industries.

      Increase in incidence of chronic diseases, coupled with need for rapid diagnostic techniques, is contributing to the increase in adoption of ISH.

      The global In Situ Hybridization (ISH) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of In Situ Hybridization (ISH).

      Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

      Market Segment by Companies, this report covers

      Thermo Fisher Scientific

      Leica BiosystemsNussloch GmbH

      BIOVIEW

      Agilent Technologies

      Merck KGaA

      PerkinElmer Inc.

      Bio-Rad Laboratories Inc.

      NeoGenomics Laboratories Inc.

      Advanced Cell Diagnostics Inc.

      Oxford Gene Technology

      Market Segment by Regions, regional analysis covers

      North America (United States, Canada and Mexico)

      Europe (Germany, France, UK, Russia and Italy)

      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

      South America (Brazil, Argentina, Colombia)

      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers

      Instruments

      Kits & Probes

      Software

      Services

      Market Segment by Applications, can be divided into

      Cancer

      Cytogenetics

      Developmental Biology

      Infectious Diseases

      Others




      Summary:
      Get latest Market Research Reports on In Situ Hybridization (ISH) . Industry analysis & Market Report on In Situ Hybridization (ISH) is a syndicated market report, published as Global In Situ Hybridization (ISH) Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of In Situ Hybridization (ISH) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,336.82
      3,505.23
      4,673.64
      3,202.30
      4,803.44
      6,404.59
      421,567.20
      632,350.80
      843,134.40
      230,770.63
      346,155.95
      461,541.26
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report